Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000102

Director sold 1,535 shares at $1,040.00 ($1,596,400)

  • Director acquired 1,535 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BROWN MICHAEL S · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-14 Exercise or conversion : show line 1 in the form 10b5-1 +1,535 $625.60 $960,296 2,917 D
2024-06-14 Sale : show line 2 in the form 10b5-1 −1,535 $1,040.00 $1,596,400 1,382 D
Open-market sales · 1,535 sh · avg $1,040.00 · $1,596,400

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-14 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −1,535 0 D
Loading xslF345X05/edgardoc.xml…